Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 10


Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy.

Vosjan MJ, Vercammen J, Kolkman JA, Stigter-van Walsum M, Revets H, van Dongen GA.

Mol Cancer Ther. 2012 Apr;11(4):1017-25. doi: 10.1158/1535-7163.MCT-11-0891. Epub 2012 Feb 7.


Invasive growth: a MET-driven genetic programme for cancer and stem cells.

Boccaccio C, Comoglio PM.

Nat Rev Cancer. 2006 Aug;6(8):637-45. Review.


Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity.

Petrelli A, Circosta P, Granziero L, Mazzone M, Pisacane A, Fenoglio S, Comoglio PM, Giordano S.

Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5090-5. Epub 2006 Mar 17.


C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.

Lengyel E, Prechtel D, Resau JH, Gauger K, Welk A, Lindemann K, Salanti G, Richter T, Knudsen B, Vande Woude GF, Harbeck N.

Int J Cancer. 2005 Feb 10;113(4):678-82.


Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody.

Desmyter A, Decanniere K, Muyldermans S, Wyns L.

J Biol Chem. 2001 Jul 13;276(28):26285-90. Epub 2001 May 7.


Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains.

Muyldermans S, Cambillau C, Wyns L.

Trends Biochem Sci. 2001 Apr;26(4):230-5. Review.


Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs.

Els Conrath K, Lauwereys M, Wyns L, Muyldermans S.

J Biol Chem. 2001 Mar 9;276(10):7346-50. Epub 2000 Oct 25.


Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.

Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, et al.

Clin Cancer Res. 1995 Feb;1(2):147-54.


Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.

Di Renzo MF, Olivero M, Serini G, Orlandi F, Pilotti S, Belfiore A, Costantino A, Vigneri R, Angeli A, Pierotti MA, et al.

J Endocrinol Invest. 1995 Feb;18(2):134-9. No abstract available.


Early and late events in the development of human breast cancer.

Smith HS, Stern R, Liu E, Benz C.

Basic Life Sci. 1991;57:329-37; discussion 337-40. Review.


Supplemental Content

Support Center